October 20, 2017 10:45 AM ET

Healthcare Providers and Services

Company Overview of Integrated Diagnostics Holdings plc

Company Overview

Integrated Diagnostics Holdings plc provides various medical diagnostics services to patients and other laboratories in Egypt, Jordan, and Sudan. The company offers pathology and molecular diagnostics, genetics testing, and basic radiology services. It provides diagnostics services in the areas of immunology, hematology/coagulation, clinical chemistry, parasitology, microbiology/infectious diseases, toxicology, cytology, surgical pathology, flow cytometry, molecular biology, cytogenetic, hepatitis, and influenza. As of December 31, 2015, the company operated 314 labs. Integrated Diagnostics Holdings plc was founded in 1979 and is headquartered in Saint Helier, the Channel Islands.

12 Castle Street

Saint Helier,  JE2 3RT

Channel Islands

Founded in 1979

4,688 Employees

Phone:

44 15 3484 7000

Key Executives for Integrated Diagnostics Holdings plc

Group Chief Executive Officer and Executive Director
Age: 48
Total Annual Compensation: £3.9M
Compensation as of Fiscal Year 2015.

Integrated Diagnostics Holdings plc Key Developments

Integrated Diagnostics Holdings plc(LSE:IDHC) dropped from S&P Global BMI Index

Integrated Diagnostics Holdings plc(LSE:IDHC) dropped from S&P Global BMI Index

Integrated Diagnostics Holdings plc Reports Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2017; Reaffirms Earnings Guidance for the Year 2017

Integrated Diagnostics Holdings plc reported unaudited consolidated earnings results for the six months ended June 30, 2017. For the quarter, the company reported revenue of EGP 685,133,000 against EGP 552,540,000 a year ago. Operating profit was EGP 224,243,000 against EGP 224,030,000 a year ago. Profit before tax was EGP 226,048,000 against EGP 198,612,000 a year ago. Profit attributed to owners of the company was EGP 155,344,000 against EGP 123,319,000 a year ago. Basic and diluted earnings per share were EGP 1.04 against EGP 0.82 a year ago. Net cash from operating activities was EGP 129,611,000 against EGP 112,047,000 a year ago. Acquisition of property, plant and equipment was EGP 103,228,000 against EGP 21,742,000 a year ago. EBITDA was EGP 255,343,000 against EGP 244,932,000 a year ago. For the full year 2017, the company continues to target revenue growth in excess of 20%, as well as EBITDA margins at or above 40%. EBITDA margin was under pressure in first half of 2017 owing predominantly to a temporary sales slowdown in June 2017 as a result of Ramadan and the subsequent holiday.

Integrated Diagnostics Holdings plc Reports Unaudited Consolidated Earnings Results for the First Quarter of 2017; Provides Earnings Guidance for the Full Year of 2017

Integrated Diagnostics Holdings plc reported unaudited consolidated earnings results for the first quarter of 2017. For the quarter, the company's revenues increased 26% year on year to EGP 346.3 million, driven by a combination of the favourable impact of foreign currency translation of results from the company's Jordanian and Sudanese subsidiaries into Egyptian pounds; better pricing; and higher patient and test volumes. Operating profit gained 7% year on year to EGP 122.9 million, with SG&A expenses rising slightly as a percentage of sales due mainly to the translation of the salaries of the Group's Jordanian subsidiary into Egyptian pounds. EBITDA was 9% higher in at EGP 136.3 million against EGP 125 million a year ago. Net profit increased 6% to EGP 88.7 million against EGP 84 million a year ago. For the full year 2017, the company continues to target revenue growth in excess of 20%, as well as EBITDA margins at or above 40%. While the EBITDA margin was 39% in first quarter of 2017, management expects the negative impact of the currency translation impact on costs to be less pronounced as 2017 progresses.

Similar Private Companies By Industry

Company Name Region
Amdipharm International Limited Europe
Elli Investments Limited Europe
Genseq Limited Europe
Grove Limited Europe
Health Properties (Bath) Limited Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Bertelsmann AG Europe

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Integrated Diagnostics Holdings plc, please visit www.idhcorp.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.